MedPath

Cross-sectional and longitudinal assessment of patient-reported outcome according to treatment options in patients with asymptomatic papillary thyroid microcarcinoma

Not Applicable
Recruiting
Conditions
Papillary thyroid carcinoma
Registration Number
JPRN-UMIN000037962
Lead Sponsor
ippon Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
550
Inclusion Criteria

Not provided

Exclusion Criteria

Patients younger than 18 years old.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient-reported outcome cross-sectionally assessed by SF-36 and STAI for patients with asymptomatic papillary thyroid carcinoma (cT1aN0M0) who have already underwent active surveillance, immediate conventional surgery and immediate endoscopic surgery since 1995.
Secondary Outcome Measures
NameTimeMethod
ongitudinal patient-reported outcome prospectively assessed by SF-36 and STAI for patients with asymptomatic papillary thyroid carcinoma (cT1aN0M0) who start to undergo active surveillance, immediate conventional surgery and immediate endoscopic surgery from now on.
© Copyright 2025. All Rights Reserved by MedPath